Literature DB >> 19683057

One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector.

Qi Zhao1, Yin-Wah Chan, Susanna Sau-Tuen Lee, Wing-Tai Cheung.   

Abstract

Millions of candidate clones are commonly obtained following rounds of phage-displayed antibody library panning, and expression of those selected single-chain variable fragment (scFv) is required for secondary functional screening to identify positive clones. Large scale functional screening is often hampered by the time-consuming and labor-intensive subcloning of those candidate scFv clones into a bacterial expression vector carrying an affinity tag for scFv purification and detection. To overcome the limitations and to develop a multiplex approach, an improved hexahistidine tag phagemid vector was constructed for one-step scFv expression and purification. By using hexahistidine as an affinity tag, soluble scFvs can be rapidly and cost-effectively captured from Escherichia coli periplasmic extracts. For proof-of-concept, feasibility of the improved phagemid vector was examined against two scFvs, L17E4d targeting a cell surface antigen and L18Hh5 recognizing a monoclonal antibody (mAb). Using 1 ml of Ni-NTA agarose, 0.2-0.5 mg of soluble scFv was obtained from 1 L of bacteria culture, and the purified scFvs bound specifically to their target antigens with high affinity. Moreover, using two randomly selected hapten-specific scFv phage clones, it was demonstrated that the display of scFvs on phage surface was not affected by the hexahistidine affinity tag. These results suggest the improved phagemid vector allows the shuttle of phage-displayed antibody library panning and functional scFv production. Importantly, the improved phagemid vector can be easily adapted for multiplex screening.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683057     DOI: 10.1016/j.pep.2009.08.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.

Authors:  Qi Zhao; Mahiuddin Ahmed; Hong-fen Guo; Irene Y Cheung; Nai-Kong V Cheung
Journal:  J Biol Chem       Date:  2015-04-07       Impact factor: 5.157

2.  Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity.

Authors:  Qi Zhao; Yang Feng; Zhongyu Zhu; Dimiter S Dimitrov
Journal:  Mol Cancer Ther       Date:  2011-07-12       Impact factor: 6.261

3.  Drop-out phagemid vector for switching from phage displayed affinity reagents to expression formats.

Authors:  Kritika Pershad; Mark A Sullivan; Brian K Kay
Journal:  Anal Biochem       Date:  2011-03-01       Impact factor: 3.365

4.  N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.

Authors:  Dezhi Li; Jie Liu; Li Zhang; Tianshu Xu; Junheng Chen; Liping Wang; Qi Zhao
Journal:  Virol Sin       Date:  2015-12-21       Impact factor: 4.327

5.  Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation.

Authors:  Dezhi Li; Rui Gong; Jun Zheng; Xihai Chen; Dimiter S Dimitrov; Qi Zhao
Journal:  Biochem Biophys Res Commun       Date:  2017-02-13       Impact factor: 3.575

6.  Construction and characterization of single-chain variable fragment antibody library derived from germline rearranged immunoglobulin variable genes.

Authors:  Man Cheng; Shirley Y W Chan; Qi Zhao; Elaine Y M Chan; Shannon W N Au; Susanna S T Lee; Wing-Tai Cheung
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

7.  Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential.

Authors:  Q Zhao; M Ahmed; D V Tassev; A Hasan; T-Y Kuo; H-F Guo; R J O'Reilly; N-K V Cheung
Journal:  Leukemia       Date:  2015-05-19       Impact factor: 11.528

8.  A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells.

Authors:  Zhizhen Chen; Jie Liu; Dafeng Chu; Yaming Shan; Guixing Ma; Hongmin Zhang; Xiaohua Douglas Zhang; Pu Wang; Qiang Chen; Chuxia Deng; Weizao Chen; Dimiter S Dimitrov; Qi Zhao
Journal:  Int J Biol Sci       Date:  2018-05-21       Impact factor: 6.580

9.  Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method.

Authors:  Shengyu Fu; Qi Zhao
Journal:  Antibodies (Basel)       Date:  2022-08-16

10.  Generation of anti-idiotype scFv for pharmacokinetic measurement in lymphoma patients treated with chimera anti-CD22 antibody SM03.

Authors:  Qi Zhao; Pui-Fan Wong; Susanna S T Lee; Shui-On Leung; Wing-Tai Cheung; Jun-Zhi Wang
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.